Skip to main content

Table 2 ICS and non-ICS-containing medication comparisons

From: Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review

Type of ICS-containing medication

Type of non-ICS containing medication

Number of studies

Placebo

ICS

13

 

 Fluticasone propionate

3

 

 Budesonide

6

 

 Fluticasone furoate

2

 

 Beclomethasone

1

 

 Triamicinolone acetonide

1

LABA

LABA/ICS

5

 Salmeterol

 Salmeterol/fluticasone proprionate

3

 Vilanterol

 Vilanterol/fluticasone furoate

2

Placebo

LABA/ICS

3

 

 Vilanterol/fluticasone furoate

2

 

 Salmeterol/fluticasone proprionate

1

LABA

ICS

3

 Vilanterol

 Fluticasone furoate

2

 Salmeterol

 Fluticasone proprionate

1

LAMA

LAMA/ICS

2

 Tiotropium

 Glycopyyronium/beclomethasone/fluticasone proprionate

1

 Tiotropium

 Tiotropium/beclothmethasone/fluticasone proprionate

1

LAMA

LAMA + LABA/ICS

1

 Tiotopium

 Tiotropium + formaterol/budesonide

1

  1. Notes: numbers do not add up to the total number of studies included in the systematic review due to multiple ICS or non-ICS containing medications used in some studies. Medications in bold indicate higher level subgroups of ICS and non-ICS containing medications
  2. Abbreviations: ICS Inhaled corticosteroid, LABA Long acting beta-agonist, LAMA Long acting muscarinic antagonist